Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 5/20 | 0.33 |
| ▸ | CES1 | P23141 | 5/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5483154 | 0.93 | SOAT1 (0.39) | SOAT1TP53MEN1FAAHCYP1A2 | |
| SCHEMBL5487758 | 0.91 | SOAT1 (0.42) | SOAT1TP53MEN1FAAHCYP1A2 | |
| SCHEMBL5487841 | 0.86 | MEN1 (0.30) | SOAT1TP53MEN1FAAHCYP1A2 | |
| SCHEMBL6047432 | 0.79 | AKR1B1 (0.42) | TP53MEN1KMT2ACES2CES1 | |
| SCHEMBL5553516 | 0.76 | CES1 (0.37) | TP53CA1CES2CES1EPHX1 | |
| SCHEMBL30701400 | 0.74 | SOAT1 (0.57) | SOAT1TP53MEN1FAAHCYP1A2 | |
| SCHEMBL30701337 | 0.74 | SOAT1 (0.57) | SOAT1TP53MEN1FAAHCYP1A2 | |
| SCHEMBL320488 | 0.72 | — | — | |
| SCHEMBL11418684 | 0.71 | TSHR (0.43) | MEN1KMT2AALDH1A1 | |
| SCHEMBL13663103 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023127857-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | 株式会社理研ジェネシス | 2023-07-06 | — | — | WO | disclosed |
| WO-2022065413-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | 株式会社理研ジェネシス | 2022-03-31 | — | — | WO | disclosed |
| WO-2020203896-A1 | NEW ARTIFICIAL NUCLEIC ACID, PRODUCTION METHOD THEREFOR, AND USE THEREOF | シスメックス株式会社 | 2020-10-08 | — | — | WO | disclosed |
| EP-2415777-B1 | PROCESS FOR PRODUCING NUCLEOSIDE | TAKEDA PHARMACEUTICAL (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-8653254-B2 | Process for producing nucleoside | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20120071646-A1 | PROCESS FOR PRODUCING NUCLEOSIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2415777-A1 | PROCESS FOR PRODUCING NUCLEOSIDE | Takeda Pharmaceutical Company Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071646-A1 | PROCESS FOR PRODUCING NUCLEOSIDE | NUDT1, PNP, HPRT1 | SOAT1 2356/4885TP53 3673/4885MEN1 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.